Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Virtonomy.io logo — Accelerate and de-risk medical device development with digit...

Virtonomy.io

Accelerate and de-risk medical device development with digital patient twins and simulation

Founded 2019 Germany Munchen, Germany 23 employees Total: $3.55M Biotechnology, Health Care

General Information

Company Name Virtonomy.io
Founded Year 2019
Location Germany Munchen, Germany
Employees 23
Industries Biotechnology, Health Care
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Virtonomy.io. To contact Virtonomy.io, visit virtonomy.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Virtonomy.io compare?

A PDF of Virtonomy.io and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Virtonomy.io soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Virtonomy.io

Virtonomy.io is an innovative player in the Biotechnology and Health Care sectors, based in Germany. Founded in 2019, the company has quickly positioned itself as a forward-thinking startup with its digital twin technology.

Their flagship innovation, v-Patients, provides a platform for medical device developers to conduct development and testing virtually. This unique approach significantly reduces development time, lowers risks and expenses, and alleviates regulatory challenges. Utilizing a comprehensive and continuously updating database of real clinical data, Virtonomy.io captures anatomical variability, demographic diversity, and pathological conditions to enhance simulation accuracy.

In a recent funding round on 01 April 2023, the company raised €3.50M through an Early VC investment. Esteemed investors include Bayern Kapital, Brinc, N&V Capital, Springboard Health Angels, Pace Ventures, Initiative for Industrial Innovators, Accenture, and Honey Stone VC. This strategic backing underscores Virtonomy's potential within the medical innovation landscape.

Business keywords: digital patient twins, medical device development, virtual environment testing, clinical data integration, anatomical variability, pathological simulation, AI in medtech, multi-physics simulations, predictive analytics for healthcare, digital health solutions, regulatory burden reduction, simulated clinical trials, SaaS for medtech, cardiac database utilization, innovative device acceleration

Services & Products

virtual patient simulations
digital twin technology
regulatory consulting
virtual testing plans
advanced anatomical studies

Target Customers

medical device developers cardiovascular device companies research and development teams regulatory bodies healthcare technology innovators

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €3.50M 8
Bayern Kapital Brinc N&V Capital
Bayern Kapital, Brinc +6
01 Apr 2023
Seed Undisclosed -
01 Apr 2021
Convertible Note €50.00K 1
EIT Health
01 Jun 2020
Seed Undisclosed 2
Unternehmertum Initiative for Industrial Innovators
Unternehmertum, Initiative for Industrial Innovators
01 Jan 2020

Virtonomy.io Alternatives & Competitors

View All Alternatives
Virtonomy.io vs
Lindus
Lindus United States

The Accountable Research Organization, engineered to give sponsors confidence and control over their...

Series A
215 employees
Biotechnology, Health Care
Virtonomy.io vs
Newcells Biotech (Axol Bioscience)
Newcells Biotech (Axol Bioscience) United Kingdom

The Newcells ophthalmology business was acquired by Axol Bioscience

12 employees
Biotechnology, Health Care
Virtonomy.io vs
Charles River Laboratories
Charles River Laboratories United States

Together, We Create Healthier Lives

IPO
14325 employees
Biotechnology, Health Care
View all alternatives

FAQ About Virtonomy.io

Accelerate and de-risk medical device development with digital patient twins and simulation
Virtonomy.io was founded in 2019.
Virtonomy.io is headquartered in Munchen, Germany.
Virtonomy.io operates in Biotechnology and Health Care. Its work centres on digital patient twins, medical device development, virtual environment testing and clinical data integration. Its customers include medical device developers, cardiovascular device companies and research and development teams.
Virtonomy.io has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Virtonomy.io has approximately 23 employees.
Virtonomy.io has completed 4 funding rounds, raising a total of $3.55M.
Virtonomy.io offers: virtual patient simulations, digital twin technology, regulatory consulting, virtual testing plans, advanced anatomical studies.
Top alternatives and competitors to Virtonomy.io include Lindus, Newcells Biotech (Axol Bioscience), Charles River Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Virtonomy.io and Lindus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Virtonomy.io, https://bouncewatch.com/company/virtonomy, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout